Key Metrics
11.9
Heat Index-
Impact LevelMedium
-
Scope LevelNational
-
Last Update2026-03-23
Key Impacts
Positive Impacts (8)
Negative Impacts (1)
Event Overview
A pharmaceutical company shifts its focus to the cryptocurrency sector, rebranding and changing its stock code. The move follows a significant investment in digital assets, including tokens and stablecoins, indicating a strategic pivot towards the growing crypto market.
Collect Records
NovaBay Pharmaceuticals Renamed to Stablecoin Development Corporation, Shifts to Crypto and Stablecoin Business
NovaBay Pharmaceuticals, a U.S. pharmaceutical company, has announced its rebranding to Stablecoin Development Corporation, with the stock code changing from NBY to SDEV. The company is transitioning to focus on cryptocurrency and stablecoin business. Previously, the company raised 944 million SKY tokens (approximately $58 million), $25 million in cash, and $51 million in stablecoins through private placement. Additionally, it purchased 10.9 billion SKY tokens at an average price of $0.065, spending a total of $70.7 million. As of March 16, the company holds 20.6 billion SKY tokens, representing 8.78% of the total supply, with a market value of approximately $1.47 billion. The company also received 26.6 million tokens as staking rewards. SKY is the governance token for Sky Protocol, formerly MakerDAO, with a total supply of about 234.6 billion tokens, and the current staking annualized yield exceeds 10%.